Literature DB >> 2328405

Simultaneous perfusion of rat isolated superior mesenteric arterial and venous beds: comparison of their vasoconstrictor and vasodilator responses to agonists.

T D Warner1.   

Abstract

1. A new isolated perfused preparation is described that allows a direct comparison to be made of the responses of the perfused arterial and retrogradely perfused venous circulations of the rat superior mesenteric vascular bed. 2. In experiments comparing the responses of the intact arterially perfused mesentery and small intestine to those of the same preparation following removal of the intestine and division of the circulations, the increases in perfusion pressure produced by arginine-vasopressin (30 pmol) and noradrenaline (1 nmol) were retained by the arterial circulation and those induced by angiotensin II (30 pmol) by the venous circulation. Endothelin-1 (30 pmol) constricted both portions of the vasculature but the prolonged nature of its response was associated with only the venous vessels. 3. In the simultaneously perfused arterial and venous preparation arginine vasopressin (3-100 pmol) was a selective constrictor of the arterial circulation and angiotensin II (3-100 pmol) of the venous circulation. In addition, noradrenaline (0.3-10 nmol), 5-hydroxytryptamine (0.3-10 nmol) and KCl (1-60 micromol) were more active as constrictors of the arterial than the venous vessels, and U46619 (10-300 pmol) a more active constrictor of the venous than the arterial vessels. Endothelin-1 (3-100 pmol) constricted both the arterial and venous portions of the vasculature but was significantly longer acting as a venoconstrictor than an arterioconstrictor. 4. Angiotensin I (300 pmol) caused constrictions of the venous circulation which were dependent upon the presence of angiotensin converting enzyme for captopril (10 microM) abolished constrictions caused by angiotensin I but not by angiotensin II. 5. In preparations preconstricted by U46619 (0.3-3 microM), acetylcholine (0.01-100 nmol), bradykinin (0.001-nmol), sodium nitroprusside (0.01-lOnmol) or isoprenaline (1-l00pmol) produced dose-related dilatations of both the arterial and the venous vasculatures, whereas adenosine diphosphate (ADP, 0.01-lOOnmol) caused dose-dependent dilatations of the arterial circulation but principally constrictions of the venous circulation. The dilatations caused by acetylcholine and bradykinin in both portions of the circulation, and by ADP in the arterial circulation, were endothelium-dependent as they were inhibited by gossypol (3 microM), whereas dilatations to sodium nitroprusside were not. 6. This preparation allows the responses of the arteries and veins of a single perfused mesenteric bed to be compared. In addition, with this preparation it is possible to demonstrate that veins, as well as arteries, show significant endothelium-dependent relaxations. It is concluded that the venous portion of the vasculature is significantly involved in the responses of the intact circulation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2328405      PMCID: PMC1917370          DOI: 10.1111/j.1476-5381.1990.tb14720.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  32 in total

1.  THE EFFECT OF GRADED VASOCONSTRICTOR FIBRE STIMULATION ON THE INTESTINAL RESISTANCE AND CAPACITANCE VESSELS.

Authors:  B FOLKOW; D H LEWIS; O LUNDGREN; S MELLANDER; I WALLENTIN
Journal:  Acta Physiol Scand       Date:  1964-08

2.  Heterogeneity of the response of venous smooth muscle to arterial endothelium-derived relaxing factor (EDRF) in respect of the role of nitric oxide.

Authors:  Y P Vedernikov; T Gräser; N Tiedt; A M Vikhert
Journal:  Basic Res Cardiol       Date:  1988 Mar-Apr       Impact factor: 17.165

3.  The distensibility of mesenteric venous microvessels.

Authors:  P Gaehtgens; U Uekermann
Journal:  Pflugers Arch       Date:  1971       Impact factor: 3.657

4.  The relationship between active constriction and passive recoil of the veins at various distending pressures.

Authors:  B Oberg
Journal:  Acta Physiol Scand       Date:  1967 Oct-Nov

5.  Precapillary control of the splanchnic vascular bed.

Authors:  H A Henrich
Journal:  J Cardiovasc Pharmacol       Date:  1985       Impact factor: 3.105

6.  Adrenergic-induced vascular adjustments--initial and escape reactions. II. Role of beta-adrenergic receptors within different sections of the isolated intestinal vascular bed.

Authors:  G Singbartl; H Henrich
Journal:  Pflugers Arch       Date:  1974-01-16       Impact factor: 3.657

7.  Evidence for endothelium-dependent vasodilation of resistance vessels by acetylcholine.

Authors:  R F Furchgott; M H Carvalho; M T Khan; K Matsunaga
Journal:  Blood Vessels       Date:  1987

8.  The hemodynamic effects of endothelin-1 in the pithed rat.

Authors:  C E Walder; G R Thomas; C Thiemermann; J R Vane
Journal:  J Cardiovasc Pharmacol       Date:  1989       Impact factor: 3.105

9.  Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor.

Authors:  G de Nucci; R Thomas; P D'Orleans-Juste; E Antunes; C Walder; T D Warner; J R Vane
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

10.  Inhibitors of acyl-coenzyme A:lysolecithin acyltransferase activate the production of endothelium-derived vascular relaxing factor.

Authors:  U Förstermann; M Goppelt-Strübe; J C Frölich; R Busse
Journal:  J Pharmacol Exp Ther       Date:  1986-07       Impact factor: 4.030

View more
  18 in total

1.  Effects of endothelin-1 on vascular permeability in the conscious rat: interactions with platelet-activating factor.

Authors:  J G Filep; M G Sirois; A Rousseau; A Fournier; P Sirois
Journal:  Br J Pharmacol       Date:  1991-12       Impact factor: 8.739

2.  Activities of endothelin-1 in the vascular network of the rabbit ear: a microangiographic study.

Authors:  M D Randall; D H Edwards; T M Griffith
Journal:  Br J Pharmacol       Date:  1990-12       Impact factor: 8.739

3.  Induction by endotoxin of nitric oxide synthase in the rat mesentery: lack of effect on action of vasoconstrictors.

Authors:  J A Mitchell; K L Kohlhaas; R Sorrentino; T D Warner; F Murad; J R Vane
Journal:  Br J Pharmacol       Date:  1993-05       Impact factor: 8.739

4.  Effect of PAF on rat lung vascular permeability: role of platelets and polymorphonuclear leucocytes.

Authors:  M G Sirois; W T de Lima; A J de Brum Fernandes; R J Johnson; G E Plante; P Sirois
Journal:  Br J Pharmacol       Date:  1994-04       Impact factor: 8.739

5.  Endothelium-dependent mesenteric vasorelaxant effects and systemic actions of endothelin (16-21) and other endothelin-related peptides in the rat.

Authors:  S A Douglas; C R Hiley
Journal:  Br J Pharmacol       Date:  1991-10       Impact factor: 8.739

6.  Enhancement by endothelin-1 of microvascular permeability via the activation of ETA receptors.

Authors:  J G Filep; M G Sirois; E Földes-Filep; A Rousseau; G E Plante; A Fournier; M Yano; P Sirois
Journal:  Br J Pharmacol       Date:  1993-07       Impact factor: 8.739

7.  Effects of the ETA/ETB receptor antagonist, bosentan on endothelin-1-induced myocardial ischaemia and oedema in the rat.

Authors:  J G Filep; A Fournier; E Földes-Filep
Journal:  Br J Pharmacol       Date:  1995-09       Impact factor: 8.739

8.  Characterization of receptors for kinins and neurokinins in the arterial and venous mesenteric vasculatures of the guinea-pig.

Authors:  N Berthiaume; A Claing; D Regoli; T D Warner; P D'Orléans-Juste
Journal:  Br J Pharmacol       Date:  1995-08       Impact factor: 8.739

9.  Characterization of the non-adrenergic/non-cholinergic response to perivascular nerve stimulation in the double-perfused mesenteric bed of the mouse.

Authors:  E Legros; C R Tirapelli; E Carrier; I Brochu; A Fournier; P D'Orléans-Juste
Journal:  Br J Pharmacol       Date:  2007-10-01       Impact factor: 8.739

10.  Endothelin-1 inhibits PAF-induced paw oedema and pleurisy in the mouse.

Authors:  M G Henriques; G A Rae; R S Cordeiro; T J Williams
Journal:  Br J Pharmacol       Date:  1992-07       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.